Artículos, noticias y otros contenidos relacionados con la Seguridad del Paciente en general y especialmente en Atención Primaria, publicados en nuestra cuenta de Twitter @sanoysalvoblog
´
Publicado por Sano y salvo
(Drug Safety) Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012 http://t.co/DWSQ5KbwWY#PtSafety
— Sano y salvo (@sanoysalvoblog) July 22, 2013
Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn? http://t.co/1vqvUzPeUO#PtSafety
— Sano y salvo (@sanoysalvoblog) July 22, 2013
RT @polimedlabs De la Seguridad del Paciente en Atención Primaria http://t.co/0YxpFJIneN#SegPac
— Sano y salvo (@sanoysalvoblog) July 22, 2013
“@DTB_BMJ: Tramadol painkiller could be banned from public sale, say ministers http://t.co/UZvQFbA6ci via @guardian” #PtSafety
— Sano y salvo (@sanoysalvoblog) July 22, 2013
“@vmontori: Corruption of healthcare: Big pharma mobilising patients in battle over drugs trials data http://t.co/vp4apfQylV via @guardian”
— Sano y salvo (@sanoysalvoblog) July 22, 2013
(WeMeReC) RAM y farmacovigilancia, conceptos generales http://t.co/rEP10E8khU#SegPac
— Sano y salvo (@sanoysalvoblog) July 23, 2013
“@AdverseEvent: American Diabetes Association Findings Show Older Patients at High Risk for Adverse Events http://t.co/HyvyRKOFFg” #PtSafety
— Sano y salvo (@sanoysalvoblog) July 23, 2013
La FDA investiga dos muertes tras inyección con antipsicótico de larga duración Zypadhera (pamoato de olanzapina) http://t.co/JFz5ukM91g
— Farmacia DA Oeste AP (@FarmaciaOesteAP) July 24, 2013
Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH Insulin http://t.co/Fu7wrjOLKg#PtSafety
— Sano y salvo (@sanoysalvoblog) July 24, 2013
(Drug Safety) Drug-Induced Thrombosis: An Update http://t.co/fumKUFhNOk#PtSafety
— Sano y salvo (@sanoysalvoblog) July 24, 2013
Danish Pharmacovigilance: Acute pancreatitis and hepatitis associated with the use of vildagliptin and linagliptin http://t.co/BcvD3ATs1g
— Sano y salvo (@sanoysalvoblog) July 24, 2013
Danish Pharmacovigilance: Reports of adverse reactions from the use of Gardasil during the period 2009-2012 (pp 6-11) http://t.co/BcvD3ATs1g
— Sano y salvo (@sanoysalvoblog) July 24, 2013
El 32% de los pacientes con fibrilación auricular tratados con anticoagulantes orales están mal controlados http://t.co/C7tBpZ5PdT#SegPac
— Txema Coll (@txemacoll) July 24, 2013
(NHS Choices) Decongestant sprays linked to rare birth defects http://t.co/qgAlOcQP2T#PTSafety
— Sano y salvo (@sanoysalvoblog) July 25, 2013
Curso de Experto Universitario en Seguridad del Paciente, on-line 30 ECTS @uned 4ª convocatoria http://t.co/ppm17wxdOC
— Seguridad Paciente (@seguridadpacien) July 7, 2013
The time-efficiency principle: time as the key diagnostic strategy in primary care http://t.co/JX4HsWwWIC#PtSafety v @enriquegavilan
— Sano y salvo (@sanoysalvoblog) July 25, 2013
Prescripción responsable. Para leer con calma, hoy en NEJM http://t.co/nNCznTo1Zb vía @JesusmRedondo
— Prescripc Prudente (@PrescripcP) July 25, 2013
RT @EMA_News No new concerns for #GLP-1 therapies identified on the basis of available evidence: http://t.co/woPKHQ1Pp8#PtSafety
— Sano y salvo (@sanoysalvoblog) July 26, 2013
RT @EMA_News We recommend suspension of marketing authorisations for oral #ketoconazole: http://t.co/4hryR60Tx4#PtSafety
— Sano y salvo (@sanoysalvoblog) July 26, 2013
Blog CADIME: Seguridad comparada de estatinashttp http://t.co/flrKj4BokJ#SegPac
— Sano y salvo (@sanoysalvoblog) July 26, 2013
RT @rafabravo Top 10 Patient-Safety Strategies Update http://t.co/zN8vSLbiCk#PtSafety
— Sano y salvo (@sanoysalvoblog) July 26, 2013
MT @FDA_Drug_Info Drug Safety Communication: FDA limits ketoconazole tablets use: http://t.co/gPjI6PZsdq#PtSafety
— Sano y salvo (@sanoysalvoblog) July 26, 2013
“@pediamecum: Informe 2012 sobre EudraVigilance, base de datos sobre sospechas de efectos adversos de medicamentos http://t.co/NJX2oDIWQn”
— Sano y salvo (@sanoysalvoblog) July 26, 2013
La agencia francesa propone retirar la bromocriptina para suprimir la lactancia #SegPachttp://t.co/qCDpraWE3f
— Sano y salvo (@sanoysalvoblog) July 27, 2013
(Drug Safety) Tendon Injury and Fluoroquinolone Use: A Systematic Review http://t.co/XcdMYJB230#PtSafety
— Sano y salvo (@sanoysalvoblog) July 28, 2013
(FDA) Ketoconazol - Potentially Fatal Liver Injury, Risk of Drug Interactions and Adrenal Gland Problems http://t.co/zstXgHLDri#PtSafety
— Sano y salvo (@sanoysalvoblog) July 28, 2013
How Many Contemporary Medical Practices Are Worse Than Doing Nothing or Doing Less? Around 40%. Ioannidis. http://t.co/x4491vdVga
— Juan Gérvas (@JuanGrvas) July 24, 2013
Do Antidepressants Increase Warfarin Bleeding Risk? http://t.co/8L3WoDTWm6 vía @manoloacosta2#PtSafety
— Sano y salvo (@sanoysalvoblog) July 28, 2013
Sobre la seguridad y coste-eficacia de las Tiras reactivas de glucosa en envase individual http://t.co/YQ4T9g72lP#SegPac
— Nory Gómez Sayago (@ngsayago) July 28, 2013
The New York Times: European Regulator Finds Little Risk in Diabetes Drugs http://t.co/EAfUh0QKCz#incretins#PtSafety
— Sano y salvo (@sanoysalvoblog) July 28, 2013
Discrepancia entre la prescripción médica y el juicio farmacéutico. #farmacéuticos, profesionales clave en la #SegPachttp://t.co/lmEsfQ1d4U
— Sano y salvo (@sanoysalvoblog) July 29, 2013
FDA approves label changes for mefloquine hydrochloride due to risk of serious psychiatric and nerve side effects http://t.co/2SN7gaM7Hj
— Sano y salvo (@sanoysalvoblog) July 29, 2013
(JAMA) Overdiagnosis and Overtreatment in Cancer. An Opportunity for Improvement http://t.co/qf5pRhN2sh vía @JesusmRedondo
— Sano y salvo (@sanoysalvoblog) July 29, 2013
Laxantes con picosulfato/citrato magnésico (CitraFleet® en España): riesgo de convulsiones http://t.co/GWl3jEq4zo vía @Mavegare#SegPac
— Sano y salvo (@sanoysalvoblog) July 29, 2013
(Prescrire) Guías de práctica clínica dignas de desconfianza: http://t.co/S9UNdkJj0X vía @rincondesisifo#SegPac
— Sano y salvo (@sanoysalvoblog) July 29, 2013
¿Cuántas prácticas médicas contemporáneas son peores que no hacer nada o hacer menos?: En este avance ... http://t.co/l4ZToigVS1#SegPac
— Sano y salvo (@sanoysalvoblog) July 29, 2013
Aproximación a los costes de la no seguridad en el Sistema Nacional de Salud http://t.co/HK4DZ2MmRS#SegPac
— Sano y salvo (@sanoysalvoblog) July 30, 2013
´
(BMJ) Remember Barbara Starfield: primary care is the health system’s bedrock http://t.co/MiV4Vs01oy#PtSafet#PrimaryCare
— Sano y salvo (@sanoysalvoblog) July 30, 2013
(BMJ) Problem based learning, litigation, and EWTD contribute to too much medicine http://t.co/6Uc9PGACTD#PtSafety
— Sano y salvo (@sanoysalvoblog) July 30, 2013
(BMJ) European drugs agency clashes with scientists over safety of GLP-1 drugs http://t.co/iGQCaJHNP8#PtSafety
— Sano y salvo (@sanoysalvoblog) July 30, 2013
(BMJ) Drug industry pledge on access to trial data is met with scepticism http://t.co/pmsB1CK2WT#AllTrials#PtSafety
— Sano y salvo (@sanoysalvoblog) July 30, 2013
(BMJ) Sharing data from clinical trials: where we are and what lies ahead http://t.co/eWhiBuIdG7#Alltrials#PtSafety
— Sano y salvo (@sanoysalvoblog) July 30, 2013
Cribado cancer de pulmon: la radiografia de torax más citologia produce mas daños que beneficios. #SegPachttp://t.co/lfezFOn23G
— Txema Coll (@txemacoll) July 29, 2013
NIHR Greater Manchester #PrimaryCare Patient Safety Translational Research Centre http://t.co/evzPpO7SxG#PtSafety via @AEGRIS2
— Sano y salvo (@sanoysalvoblog) July 31, 2013
“@AdverseEvent: Japanese Officials Investigate Severe Skin Reactions Associated with Blood Pressure Drug Diovan http://t.co/gmoz2PZSmX”
— Sano y salvo (@sanoysalvoblog) July 31, 2013
Metoclopramida: restricciones de uso, actualización de indicaciones y posología http://t.co/gK7B5ecnWS
— AEMPS (@AEMPSGOB) July 30, 2013
The epidemiology of malpractice claims in #PrimaryCare: a systematic review @BMJ_Openhttp://t.co/Pe8r8Wqbcw#PtSafety
— Sano y salvo (@sanoysalvoblog) August 1, 2013
"@BMJ_Open Bilateral mastectomies doubled in UK over last decade & more than tripled for women without breast cancer http://t.co/xcTbzYwi25"
— Sano y salvo (@sanoysalvoblog) August 1, 2013
Improving Patient and Worker Safety: Exploring Opportunities for Synergy #Ptsafety#segPachttp://t.co/sVVI5Ms85U
— AEGRIS (@AEGRIS2) August 1, 2013
Appropriate vs Clinically Useful Diagnostic Tests. JAMA Internal Medicine http://t.co/0jad5UyrDa
— Sano y salvo (@sanoysalvoblog) August 1, 2013
Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections. The Lancet:http://t.co/00uu8HoZWr
— Sano y salvo (@sanoysalvoblog) August 1, 2013
“@FDA_Drug_Info Drug Safety Communication: FDA warns of rare but serious skin reactions with acetaminophen http://t.co/enwzbwxIQU” #PtSafety
— Sano y salvo (@sanoysalvoblog) August 1, 2013
Organizaciones patológicas. Interesante entrada sobre #segpac tomando como ejemplo el accidente d Santiago x @sminuehttp://t.co/FZ6Vv8HK7W
— Pastora Pérez (@pasperper) August 1, 2013
#PrescripciónPrudente en embarazo. Prescrire http://t.co/Jpz0AbKg3B Pregnancy: drugs to avoid http://t.co/fgyrpmisWu#SegPac#PtSafety
— Sano y salvo (@sanoysalvoblog) August 2, 2013
Medication during pregnancy: 10 principles to avoid adverse effects in the unborn child. Prescrire:http://t.co/whX4SuuOJO#PtSafety
— Sano y salvo (@sanoysalvoblog) August 2, 2013
Atención al paciente. De la esperanza a la confianza: Seguridad del paciente en Atención Primaria http://t.co/Tm4K1qnKPm#SegPac
— Sano y salvo (@sanoysalvoblog) August 3, 2013
Prescripción Saludable: Prescripción_responsable http://t.co/NFgQB1JMxW Traducción de NEJM en @nogracias_eu#PrescripciónPrudente#SegPac
— Sano y salvo (@sanoysalvoblog) August 3, 2013
Objetivos coherentes para una prescripción responsable http://t.co/nVgKGmmZIf de @fatienzam#PrescripciónPrudente#SegPac
— Sano y salvo (@sanoysalvoblog) August 3, 2013
Studies show Role of #Nurse Fatigue in Patient Safety http://t.co/1yd7uKArwk Preventative measures to improve fatigue, #ptsafety. #health
— Amber (@aeamarsh) August 3, 2013
Publicado por Sano y salvo